News
"+PlusHLTH™ fills a growing demand for natural supplements that address today's key wellness challenges, offering consumers a cannabinoid-free alternative or complement to our best-selling CBD ...
--CV Sciences, Inc., a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced the launch of their ...
CV Sciences also noted that the CBD watchdog Leafreport tested over 3,000 products in 2021 and voted CV Sciences’ +PlusCBD Oil as one of the Top 10 Most Transparent and Accurate Brands in ...
CV Sciences' initial drug candidate (CVSI-007) contains nicotine and CBD to support the cessation of smokeless tobacco use and addiction.
Hemp CBD manufacturer CV Sciences, Inc.CVSI has launched +PlusCBD Reserve Collection softgels to support stress relief and relaxation. This new CBD collection will be available online starting ...
The patent covers methods of treating smokeless tobacco addiction by administering pharmaceutical formulations containing CBD and nicotine. CV Sciences has also filed corresponding patent ...
The patent covers methods of treating smokeless tobacco addiction by administering pharmaceutical formulations containing CBD and nicotine. CV Sciences has also filed corresponding patent applications ...
CV Sciences' initial drug candidate (CVSI-007) contains nicotine and CBD to support the cessation of smokeless tobacco use and addiction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results